OUR PORTFOLIO COMPANIES
As early stage investors, Mission Cure Capital expects above-market returns, but our life science portfolio companies are much more than investment opportunities.
As chronic pancreatitis patients, family members and impact investors, we fuel problem-solvers who share our urgency and measure success by improvements in disease progression and quality of life.
Ariel Precision Medicine
Ariel Precision Medicine (Ariel) is a genomic health information technology company that is spearheading a new approach to complex disease care using precision medicine for the diagnosis, monitoring & tailored treatment of complex disease, starting with pancreatitis, pancreatic cancer, gastrointestinal and other complex diseases.